Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Health Security Systems Australia (HSSA) is a division of DMTC Ltd, an Australian not-for-profit company that facilitates collaborative research and development to enhance national sovereign industrial capability. HSSA specifically focuses on the development of medical countermeasures (MCM), including vaccines, therapeutics, and diagnostic technologies designed to protect against chemical, biological, radiological, and nuclear (CBRN) threats as well as emerging infectious diseases. The organization operates by partnering with the Australian Department of Defence, the Department of Health and Aged Care, academic institutions, and industry leaders to manage a diverse portfolio of high-impact R&D projects. Their work encompasses the entire development pipeline from early-stage research to advanced manufacturing and point-of-care diagnostic deployment. By bridging the gap between research and commercialization, HSSA plays a critical role in Australia's national health security and pandemic preparedness strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Health Security Systems Australia.